EffRx will be attending BIO-Europe 2026, taking place from November 9–11 in Cologne, Germany. BIO-Europe is one of the leading partnering events for the global biotechnology and biopharmaceutical industry, connecting pharma and biotech companies, investors, and industry decision-makers from across the life sciences community. Bringing together a broad range of international stakeholders, the event offers a valuable platform to identify new opportunities, connect with potential partners, and initiate discussions around future collaborations.

At BIO-Europe, EffRx will be focused on identifying new in-licensing and collaboration opportunities in Switzerland and across Europe, with particular interest in niche and specialty therapeutic areas such as rare diseases, endocrinology, metabolic and musculoskeletal disorders.  We are particularly interested in late-stage and commercial-stage assets with strong potential, where a tailored market approach can create value in Switzerland and other European markets.

In addition, EffRx is looking to establish partnerships for the commercialization of Binosto® in the US, Latin America and selected Asian markets, including South Korea.